SCHEMBL268673

SCHEMBL268673

Oc1ccccc1NCc1ccccc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.78
MAPT P10636 4/20 0.78
MEN1 O00255 3/20 0.78
KMT2A Q03164 3/20 0.78
ALDH1A1 P00352 3/20 0.78
THRB P10828 2/20 0.78
ALOX12 P18054 1/20 0.78
IDO1 P14902 2/20 0.61
HSD17B10 Q99714 3/20 0.59
CA12 O43570 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
HPGD P15428 2/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 2/20 0.51
GAA P10253 2/20 0.51
MAPK1 P28482 1/20 0.51
BLM P54132 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
BACE1 P56817 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL10436174 0.98 KDM4E (0.75) KDM4EMAPTMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL6266755 0.98 KDM4E (0.75) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL6261878 0.93 MAPT (0.88) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL11510769 0.88 MEN1 (0.73) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL11509284 0.88 MAPT (1.00) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL9750717 0.87 IDO1 (0.61) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL11509875 0.86 MAPT (0.59) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL11513224 0.84 KDM4E (0.68) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL22796037 0.84 MAPT (0.73) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL19419965 0.84 MAPT (0.73) KDM4EMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101543243-B Special nano-antibacterial fresh-keeping film for papayas, and manufacturing method thereof KAI YU 2012-08-22 CN claimed
US-20110313158-A1 Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2011-12-22 US claimed
WO-2010097815-A2 A TWO COMPONENT RECYCLABLE HETEROGENEOUS CATALYST, PROCESS FOR PREPARATION THEREOF AND ITS USE FOR PREPARATION OF AMINES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-09-02 WO claimed
CN-101543243-A Special nano-antibacterial fresh-keeping film for papayas, and manufacturing method thereof KAI YU 2009-09-30 CN claimed
EP-0375668-A2 Phenylethylamines, process for their preparation and compositions containing them FISONS plc (GB) 1990-06-27 EP claimed
US-20250263547-A1 NON-DRYING ELECTROLYTE GELS FOR SOFT ELECTRODES META PLATFORMS TECHNOLOGIES, LLC 2025-08-21 US disclosed
US-20250130507-A1 METHOD FOR PRODUCING OPTICAL ELEMENT MITSUBISHI CHEMICAL CORPORATION (JP) 2025-04-24 US disclosed
US-20240270909-A1 MULTIMODULUS SILICONE RESINS BASED ON THIOL-ENE-EPOXY CHEMISTRIES META PLATFORMS TECH LLC (US) 2024-08-15 US disclosed
US-20240233765-A1 METHOD FOR PRODUCING OPTICAL ELEMENT MITSUBISHI CHEMICAL CORPORATION (JP) 2024-07-11 US disclosed
EP-4315330-A1 HALOGENATED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS META PLATFORMS TECHNOLOGIES, LLC (US) 2024-02-07 EP disclosed
EP-4308982-A1 RECORDING A LATENT HOLOGRAPHIC GRATING AND AMPLIFICATION OF ITS DYNAMIC RANGE META PLATFORMS TECHNOLOGIES, LLC (US) 2024-01-24 EP disclosed
EP-4309002-A1 RECORDING A LATENT HOLOGRAPHIC GRATING AND AMPLIFICATION OF ITS DYNAMIC RANGE META PLATFORMS TECHNOLOGIES, LLC (US) 2024-01-24 EP disclosed
EP-0122321-A1 Hydroxybenzylamino derivatives as anti-inflammatory agents MERCK & CO. INC. (US) 1984-10-24 EP disclosed
EP-0081782-A1 Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same MERCK & CO. INC. (US) 1983-06-22 EP disclosed
EP-0081782-A1 Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same MERCK & CO. INC. (US) 1983-06-22 EP disclosed
US-4250238-A EXCELLENT STABILITY OF IMAGES FORMED OF A COORDINATION COMPLEX OF A METAL-DYE DEVELOPER; MONOAZO AND TRIAZOLE DYES EASTMAN KODAK COMPANY (US) 1981-02-10 US disclosed
US-4248956-A ARYLAZO-PYRAZOLOTRIAZOLE FORMING A METAL COMPLEXED COLORFAST IMAGE EASTMAN KODAK COMPANY (US) 1981-02-03 US disclosed
US-4200753-A Water-soluble fluorescing and lasing dyes THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1980-04-29 US disclosed
US-4152452-A N-BENZYLANILINE AND DERIVATIVES WILLIAM H. RORER, INC. (US) 1979-05-01 US disclosed
US-3981869-A BENZOTHIAZOLE, BENZOXAZOLE AND INDOLE DYES BAYER AKTIENGESELLSCHAFT (DT) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313158-A1 Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines HCN2, RAC2, HCN1 KDM4E 2112/4885MAPT 3456/4885MEN1 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.